{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:58:32Z","timestamp":1781027912057,"version":"3.54.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bioorg.2019.03.058","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T11:36:21Z","timestamp":1553340981000},"page":"572-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Anupamjeet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhmani","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Priyadarshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5352-9819","authenticated-orcid":false,"given":"Bhupesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin Kumar","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.03.058_b0005","first-page":"146","article-title":"\u00dcberEineEigenartigeErkrankung Der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg. Zschr. Psychiat. Psych. gerichtl. Med."},{"key":"10.1016\/j.bioorg.2019.03.058_b0010","unstructured":"(a) WHO, Dementia, 2018. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia; (b) https:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2016.pdf."},{"key":"10.1016\/j.bioorg.2019.03.058_b0015","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1039\/b807980n","article-title":"The chemistry of Alzheimer's disease","volume":"38","author":"Rauk","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2019.03.058_b0020","unstructured":"http:\/\/www.alzforum.org\/therapeutics\/rivastigmine."},{"key":"10.1016\/j.bioorg.2019.03.058_h0025","unstructured":"http:\/\/www.alzforum.org\/therapeutics\/donepezil."},{"key":"10.1016\/j.bioorg.2019.03.058_h0030","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti\u2013amnesic and neuroprotective effects of donepezil against amyloid \u03b225\u201335 peptide\u2013induced toxicity in mice involve an interaction with the \u03c31 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.03.058_b0030","unstructured":"http:\/\/www.alzforum.org\/therapeutics\/galantamine."},{"key":"10.1016\/j.bioorg.2019.03.058_b0035","unstructured":"http:\/\/www.alzforum.org\/therapeutics\/memantine."},{"key":"10.1016\/j.bioorg.2019.03.058_b0040","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta\u2013analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bioorg.2019.03.058_b0045","unstructured":"http:\/\/www.pharmacodia.com\/web\/drug\/1_3088.html#clinical_trial."},{"key":"10.1016\/j.bioorg.2019.03.058_b0050","unstructured":"http:\/\/www.alzforum.org\/news\/research\u2013news\/tau\u2013targeting\u2013drug\u2013davunetide\u2013washes\u2013out\u2013phase\u20133\u2013trials."},{"key":"10.1016\/j.bioorg.2019.03.058_b0055","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2019.03.058_b0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2019.03.058_b0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jalz.2013.05.569","article-title":"Phase II study of the gamma\u2013secretase inhibitor avagacestat (BMS\u2013708163) in predementia Alzheimer's disease","volume":"9","author":"Coric","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2019.03.058_b0070","unstructured":"http:\/\/www.alzforum.org\/new\/detail.asp?id535222013."},{"key":"10.1016\/j.bioorg.2019.03.058_b0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.0000000000001877","article-title":"Bapineuzumab 301 and 302 Clinical Trial Investigators, Amyloid\u2013\u03b2 11C\u2013PiB\u2013PET imaging results from 2 randomized bapineuzumab phase 3 AD trials","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bioorg.2019.03.058_b0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Alzheimer's disease cooperative study steering committee, Solanezumab Study Group, Phase 3 trials of solanezumab for mild\u2013to\u2013moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.bioorg.2019.03.058_h0090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"PBT2\u2013201\u2013EURO study group, Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer's disease: a phase IIa, double\u2013blind, randomised, placebo\u2013controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2019.03.058_h0095","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal\u2013protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bioorg.2019.03.058_h0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","article-title":"Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease","volume":"158","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0105","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejmech.2018.07.033","article-title":"Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities","volume":"156","author":"Knez","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.03.058_h0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bioorg.2018.06.009","article-title":"Multi-targetable chalcone analogs to treat deadly Alzheimer's disease: current view and upcoming advice","volume":"80","author":"Zhang","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0120","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.2174\/1568026617666170707130652","article-title":"Multi\u2013targeting strategies for Alzheimer's disease therapeutics: pros and cons","volume":"17","author":"Das","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0125","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.2174\/1568026617666170717114944","article-title":"Therapeutic agents in Alzheimer's disease through a multi\u2013target directed ligands strategy: recent progress based on tacrine core","volume":"17","author":"Lin","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0130","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/1568026605666160927152728","article-title":"Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease","volume":"17","author":"Spilovska","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejmech.2015.08.052","article-title":"New multifunctional melatonin\u2013derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease","author":"Luo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0140","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","article-title":"Design, synthesis, and evaluation of orally available clioquinol\u2013moracin M hybrids as multitarget\u2013directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer's disease","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0145","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1039\/C4CP04544K","article-title":"Energetic contributions of residues to the formation of early amyloid\u2013\u03b2 oligomers","volume":"17","author":"Pouplana","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bioorg.2019.03.058_h0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cplett.2017.02.070","article-title":"Emerging structural details of transient amyloid\u2013\u03b2 oligomers suggest designs for effective small molecule modulators","volume":"675","author":"Chandra","year":"2017","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.bioorg.2019.03.058_b0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720506775697098","article-title":"Has the amyloid cascade hypothesis for Alzheimer's disease been proved?","volume":"3","author":"Hardy","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2019.03.058_h0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/acscombsci.6b00116","article-title":"Rationally designed peptides and peptidomimetics as inhibitors of amyloid\u2013\u03b2 (A\u03b2) aggregation: potential therapeutics of Alzheimer's disease","volume":"19","author":"Goyal","year":"2017","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.bioorg.2019.03.058_h0165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2174\/138161212799277752","article-title":"Peptides for therapy and diagnosis of Alzheimer's disease","volume":"18","author":"Funke","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2019.03.058_h0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/pri.28220","article-title":"D\u2013amino acid\u2013based peptide inhibitors as early or preventative therapy in Alzheimer disease","volume":"8","author":"Kumar","year":"2014","journal-title":"Prion"},{"key":"10.1016\/j.bioorg.2019.03.058_h0175","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bmc.2015.02.041","article-title":"\u03b2\u2013sheet interfering molecules acting against \u03b2\u2013amyloid aggregation and fibrillogenesis","volume":"23","author":"Francioso","year":"2015","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0180","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1021\/acschemneuro.6b00154","article-title":"Modulation of amyloid \u03b2\u2013Protein (A\u03b2) assembly by homologous C\u2013terminal fragments as a strategy for inhibiting A\u03b2 toxicity","volume":"7","author":"Li","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.03.058_h0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sbi.2014.12.004","article-title":"Inhibition of protein aggregation and amyloid formation by small molecules","volume":"30","author":"Doig","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bioorg.2019.03.058_h0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/13543776.2013.772983","article-title":"Small\u2013molecule inhibitors\/modulators of amyloid\u2013\u03b2 peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010\u20132012)","volume":"23","author":"Belluti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2019.03.058_h0195","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1039\/C6RA26737H","article-title":"Two decades of new drug discovery and development for Alzheimer's disease","volume":"7","author":"Liu","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.03.058_h0200","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1021\/bi0272151","article-title":"Metal binding and oxidation of amyloid\u2013\u03b2 within isolated senile plaque cores: Raman microscopic evidence","volume":"42","author":"Dong","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2019.03.058_h0205","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/cr300009x","article-title":"Bioinorganic chemistry of Alzheimer's disease","volume":"112","author":"Kepp","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.03.058_b0115","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1073\/pnas.2332818100","article-title":"Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid A\u03b2 production in APP23 transgenic mice","volume":"100","author":"Bayer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2019.03.058_b0120","doi-asserted-by":"crossref","first-page":"52088","DOI":"10.1039\/C4RA09193K","article-title":"Drug\u2013like chelating agents: a potential lead for Alzheimer's disease","volume":"4","author":"Huang","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.03.058_b0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.03.058_h0225","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm400567s","article-title":"Design, synthesis, and evaluation of multitarget\u2013directed resveratrol derivatives for the treatment of Alzheimer's disease","volume":"56","author":"Lu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0230","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1021\/jm300978h","article-title":"Multitarget\u2013directed benzylideneindanone derivatives: anti\u2013\u03b2\u2013amyloid (A\u03b2) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO\u2013B) inhibition properties against Alzheimer\u2019s disease","volume":"55","author":"Huang","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0235","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/cmdc.201800156","article-title":"Benzofuran and indole: promising scaffolds for drug development in Alzheimer's disease","volume":"13","author":"Goyal","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2019.03.058_h0240","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: Current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0245","unstructured":"H. Kroth, C. Hamel, P. Benderitter, W. Froestl, N. Sreenivasachary, A. Muhs, Ac Immune S.A., Preparation of 7\u2013azaindole, indole, and carbazole compounds for the treatment of diseases associated with amyloid or amyloid\u2013like proteins patent. WO2011128455A1, 2011."},{"key":"10.1016\/j.bioorg.2019.03.058_h0250","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1021\/cr200409f","article-title":"Click chemistry for drug development and diverse chemical\u2212biology applications","volume":"113","author":"Thirumurugan","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.03.058_b0140","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/jm070467l","article-title":"Quick assembly of 1,4\u2013diphenyltriazoles as probes targeting beta\u2013amyloid aggregates in Alzheimer's disease","volume":"50","author":"Qu","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_b0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejmech.2017.02.057","article-title":"Identification of dibenzylimidazolidine and triazole acetamide derivatives through virtual screening targeting amyloid beta aggregation and neurotoxicity in PC12 cells","volume":"130","author":"Das","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_b0150","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1021\/acschemneuro.5b00058","article-title":"Selectivity optimization of substituted 1,2,3\u2013triazoles as \u03b17 nicotinic acetylcholine receptor agonists","volume":"6","author":"Arunrungvichian","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.03.058_b0155","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1039\/C7SC01269A","article-title":"Multi\u2013target\u2013directed phenol\u2013triazole ligands as therapeutic agents for Alzheimer's disease","volume":"8","author":"Jones","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2019.03.058_b0160","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.3390\/molecules17078312","article-title":"From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease","volume":"17","author":"Jiaranaikulwanitch","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.03.058_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/ecp.12.74","article-title":"Polypharmacology: drug discovery for the future","volume":"6","author":"Reddy","year":"2013","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.03.058_h0285","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.molstruc.2016.12.096","article-title":"Spectroscopic investigation of bis\u2013appended 1,2,3\u2013triazole probe for the detection of Cu(II) ion","volume":"1134","author":"Ghosh","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2019.03.058_h0290","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1039\/c2an35222b","article-title":"A novel di\u2013triazole based peptide as a highly sensitive and selective fluorescent chemosensor for Zn2+ ions","volume":"137","author":"Kotha","year":"2012","journal-title":"Analyst"},{"key":"10.1016\/j.bioorg.2019.03.058_h0295","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2019.03.058_h0300","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A stepwise Huisgen cycloaddition process: copper(I)\u2013catalyzed regioselective \u201cligation\u201d of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2019.03.058_b0180","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1039\/b005605g","article-title":"Constrained phenylalanyl peptides via a [2+2+2]\u2013cycloaddition strategy","author":"Kotha","year":"2000","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2019.03.058_b0185","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1016\/j.bmcl.2008.09.096","article-title":"Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis","volume":"18","author":"Gill","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.03.058_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129509031881","article-title":"Thioflavine T interaction with amyloid \u03b2\u2013sheet structures","volume":"2","author":"LeVine","year":"1995","journal-title":"Amyloid"},{"key":"10.1016\/j.bioorg.2019.03.058_b0195","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1570-9639(02)00461-2","article-title":"Change and stabilization of the amyloid\u2013beta (1\u201340) secondary structure by fluorocompounds","volume":"1645","author":"Vieira","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.bioorg.2019.03.058_h0330","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1186\/s40064-016-2996-5","article-title":"Halogen\u2013directed drug design for Alzheimer's disease: a combined density functional and molecular docking study","volume":"5","author":"Rahman","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.bioorg.2019.03.058_h0335","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1021\/bi0601104","article-title":"Organofluorine inhibitors of amyloid fibrillogenesis","volume":"45","author":"T\u00f6r\u00f6k","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2019.03.058_b0205","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1021\/ja907045h","article-title":"Small molecule modulators of copper\u2013induced A\u03b2 aggregation","volume":"131","author":"Hindo","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.03.058_b0210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/cbic.200700111","article-title":"Redox chemistry of copper\u2013amyloid\u2013beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox\u2013potentials and aggregation state","volume":"8","author":"Guilloreau","year":"2007","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2019.03.058_b0215","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1039\/C4OB00998C","article-title":"New multi\u2013target\u2013directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol","volume":"12","author":"Mao","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_b0220","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/asia.201601461","article-title":"Para\u2013sulfonato\u2013calix[n]arenes inhibit amyloid beta\u2013peptide fibrillation and reduce amyloid cytotoxicity","volume":"12","author":"Wang","year":"2017","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.bioorg.2019.03.058_b0225","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease?","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2019.03.058_b0230","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2019.03.058_h0370","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1287\/moor.6.1.19","article-title":"Minimization by random search techniques","volume":"6","author":"Solis","year":"1981","journal-title":"Math. Meth. Oper. Res."},{"key":"10.1016\/j.bioorg.2019.03.058_h0375","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A semiempirical free energy force field with charge\u2013based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J. Comput. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818311222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818311222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:53:07Z","timestamp":1758613987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818311222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":75,"alternative-id":["S0045206818311222"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.058","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}